Richards Windham Bannister

Insider Reports History

Location
Burlington, MA
Signature
/s/ Susan Richards Windham-Bannister by Dale A. Sander as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richards Windham Bannister:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aridis Pharmaceuticals, Inc. Director Stock options 261,000 27 Jun 2024 Direct
Humacyte, Inc. Director Stock Options (right to buy) 80,000 12 Jun 2025 Direct
Humacyte, Inc. Director Stock Options (right to buy) 50,000 13 Jun 2024 Direct
Histogen Inc. Director Stock Option (right to buy) 6,835 20 Jun 2023 Direct

Insider Reports Filed by Richards Windham Bannister